课题基金 / 基金详情

Cell cycle transactivation factor E2F-4 is associate with the ganstrointestinal carcinogenesis and/or acquisition of chemoresistance

Cell cycle transactivation factor E2F-4 is associate with the ganstrointestinal carcinogenesis and/or acquisition of chemoresistance
细胞周期反式激活因子E2F-4与胃肠癌发生和/或化疗耐药性的获得有关
批准号:
11671237
负责人:
TANAKA Noriaki
金额:
$2.3万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
1999
资助国家:
日本
项目状态:
已结题
起止时间:
1999 至 2000

项目摘要

项目成果

TANAKA Noriaki的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
E2F is a family of transcription factors implicated in the regulation of gene expression required for progression through the G1-S transition. We have previously detected tumor-specific mutations at a trinucleotide repeat coding sequence of E2F-4 gene in a subset of human sporadic colorectal cancers. The purpose of this study was to investigate the potential functional consequences of these E2F-4 mutations. We transfected NIH3T3 fibroblasts with expression constructs containing wild type as well as mutant E2F-4 cDNA and the effect of the E2F-4 mutations on proliferation was examined. Alteration in transactivation of the E2F consensus promoter sequence was also examined by transient cotransfection of a E2F-4 with a DP-2 construct into cultured human cells. Transfected cell clones overexpressing mutant E2F-4 grew more rapidly and showed higher proliferative activity by increased immunohistochemical staining for proliferating cell nuclear antigen (PCNA). All three mutant forms of E2F-4 showed elevated transactivation of the E2F consensus promoter sequence. Thus, expression of mutant E2F-4s confers a growth advantage in vivo, and this effect may be related to the acquisition of a neoplastic phenotype.
期刊论文(14)
专著(0)
科研奖励(0)
会议论文
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Matsubara N, et al.: "Multiple tumors and a novel E2F-4 mutation"Digestion. 62. 213-216 (2000)
Matsubara N 等人:“多种肿瘤和新型 E2F-4 突变”消化。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
馬場正三他: "21世紀の大腸癌診断治療戦略のために HNPCC in the year2000"株式会社マイライフ社. 71 (2000)
Shozo Baba等:“2000年21世纪HNPCC的结直肠癌诊断和治疗策略” My Life Co., Ltd. 71 (2000)
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Matsubara N, et al: "The farthest 3' distal end APC mutation identified in attenuated adenomatous polyposis coli with extracolonic manifestations."Dis.Colon Rectum. 43・5. 720-721 (2000)
Matsubara N 等人:“在具有结肠外表现的减毒腺瘤性息肉病中鉴定出最远的 3 远端 APC 突变。”Dis.Colon Rectum。 720-721 (2000)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
14
    総合ビタミン製剤の連続投与が高度腎機能障害患者に及ぼす影響の解明
    • 批准号:
      19H00350
    • 项目类别:
      Grant-in-Aid for Encouragement of Scientists
    • 资助金额:
      $0.35万
    • 财政年份:
      2019
    • 负责人:
      TANAKA Noriaki
    • 依托单位:
    Contribution of chemokines and growth factors for the cervical lymph node metastasis in oral squamous cell carcinoma
    • 批准号:
      24792206
    • 项目类别:
      Grant-in-Aid for Young Scientists (B)
    • 资助金额:
      $2.75万
    • 财政年份:
      2012
    • 负责人:
      TANAKA Noriaki
    • 依托单位:
    The relationship of MMPs and growth factors in the invasion mechanism of adenoid cystic carcinoma
    • 批准号:
      20791561
    • 项目类别:
      Grant-in-Aid for Young Scientists (B)
    • 资助金额:
      $2.66万
    • 财政年份:
      2008
    • 负责人:
      TANAKA Noriaki
    • 依托单位:
    Hepatic differentiation of human embryonic stem cells and its application to the development of a bioartificial liver system
    • 批准号:
      19390334
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $12.15万
    • 财政年份:
      2007
    • 负责人:
      TANAKA Noriaki
    • 依托单位:
    海外基金